Fenugreek with reduced bitterness prevents diet-induced metabolic disorders in rats

この論文をさがす

抄録

type:text

Background: Various therapeutic effects of fenugreek (Trigonella foenum-graecum L.) on metabolic disorders have been reported. However, the bitterness of fenugreek makes it hard for humans to eat sufficient doses of it for achieving therapeutic effects. Fenugreek contains bitter saponins such as protodioscin. Fenugreek with reduced bitterness (FRB) is prepared by treating fenugreek with beta-glucosidase. This study has been undertaken to evaluate the effects of FRB on metabolic disorders in rats.

Open Access http://www.lipidworld.com/content/11/1/58 ? 2012 Muraki et al.; licensee BioMed Central Ltd.

identifier:JOS-1476-511X-11-58

収録刊行物

詳細情報 詳細情報について

問題の指摘

ページトップへ